Literature DB >> 26604460

Osteoradionecrosis of the Jaws: Clinico-Therapeutic Management: A Literature Review and Update.

Koteswara Rao Nadella1, Rama Mohan Kodali1, Leela Krishna Guttikonda1, Ashok Jonnalagadda1.   

Abstract

Osteoradionecrosis is one of the most serious oral complications of head and neck cancer treatment. It is a severe delayed radiation-induced injury, characterized by bone tissue necrosis and failure to heal for at least 3 months. In most cases osteoradionecrosis gradually progresses, becoming more extensive and painful that leads to infection and pathological fracture. The present paper provides a literature review and update on the risk factors underlying osteoradionecrosis, its clinical and diagnostic particulars, prevention and most widely accepted treatment options including the latest treatment modalities. Lastly, a new early management protocol is proposed based on the current clinical criteria relating to osteonecrosis secondary to treatment with bisphosphonates, together with the adoption of new therapies supported by increased levels of evidence.

Entities:  

Keywords:  Bisphosphonate osteonecrosis; Etiology; Osteoradionecrosis; Pathophysiology; Risk factors; Treatment options

Year:  2015        PMID: 26604460      PMCID: PMC4648774          DOI: 10.1007/s12663-015-0762-9

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  31 in total

1.  Osteoradionecrosis of the mandible: scientific basis for clinical staging.

Authors:  Harry C Schwartz; A Robert Kagan
Journal:  Am J Clin Oncol       Date:  2002-04       Impact factor: 2.339

2.  The conservative management of osteoradionecrosis of the mandible with ultrasound therapy.

Authors:  M Harris
Journal:  Br J Oral Maxillofac Surg       Date:  1992-10       Impact factor: 1.651

3.  Conservative management of osteoradionecrosis.

Authors:  J K Wong; R E Wood; M McLean
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1997-07

4.  Osteoradionecrosis: clinical experience and a proposal for classification.

Authors:  J B Epstein; F L Wong; P Stevenson-Moore
Journal:  J Oral Maxillofac Surg       Date:  1987-02       Impact factor: 1.895

5.  Osteomyelitis and osteoradionecrosis of the jaws.

Authors:  W P Titterington
Journal:  J Oral Med       Date:  1971 Jan-Mar

6.  A new concept in the treatment of osteoradionecrosis.

Authors:  R E Marx
Journal:  J Oral Maxillofac Surg       Date:  1983-06       Impact factor: 1.895

Review 7.  Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw.

Authors:  Niall M H McLeod; Vinod Patel; Atul Kusanale; Simon N Rogers; Peter A Brennan
Journal:  Br J Oral Maxillofac Surg       Date:  2010-09-22       Impact factor: 1.651

Review 8.  Paradigm shifts in the management of osteoradionecrosis of the mandible.

Authors:  Adam S Jacobson; Daniel Buchbinder; Kenneth Hu; Mark L Urken
Journal:  Oral Oncol       Date:  2010-09-16       Impact factor: 5.337

Review 9.  Radiotherapy-induced mandibular bone complications.

Authors:  Barbara A Jereczek-Fossa; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2002-02       Impact factor: 12.111

10.  The effects of high dose and highly fractionated radiation on distraction osteogenesis in the murine mandible.

Authors:  Laura A Monson; Christi M Cavaliere; Sagar S Deshpande; Alexander L Ayzengart; Steven R Buchman
Journal:  Radiat Oncol       Date:  2012-09-07       Impact factor: 3.481

View more
  17 in total

1.  In-vivo imaging of the microvasculature of the soft tissue margins of osteonecrotic jaw lesions.

Authors:  P Bastos; V Patel; F Festy; N Hosny; R J Cook
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

Review 2.  Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw.

Authors:  J Chang; A E Hakam; L K McCauley
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

3.  A challenging journey of maxillofacial implants placement and rehabilitation in an irradiated exenterated socket.

Authors:  Radhika Jain; Modhupa Ghosh; Ruchi Goel; Rekha Gupta; Priyanka Golhait; Basudeb Ghosh
Journal:  J Oral Biol Craniofac Res       Date:  2022-04-04

Review 4.  Autologous platelet concentrates in extraction sockets for the prevention of osteoradionecrosis: a systematic review of controlled clinical trials.

Authors:  Rafael Verardi Serrano; Thiago Pallin Gomes; Felipe Medeiros da Silva; Leandro Chambrone; Marcia Martins Marques; Luiz Felipe Palma
Journal:  Oral Maxillofac Surg       Date:  2022-01-20

Review 5.  Wound Healing Problems in the Mouth.

Authors:  Constantinus Politis; Joseph Schoenaers; Reinhilde Jacobs; Jimoh O Agbaje
Journal:  Front Physiol       Date:  2016-11-02       Impact factor: 4.566

6.  Retrospective study of osteoradionecrosis in the jaws of patients with head and neck cancer.

Authors:  Brena Rodrigues Manzano; Natália Garcia Santaella; Marco Aurélio Oliveira; Cássia Maria Fischer Rubira; Paulo Sérgio da Silva Santos
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2019-02-26

7.  Osteoradionecrosis of Jaw: An Institutional Experience.

Authors:  Saurabh Kumar; Catherine Chandran; Rabin Chacko; J S Jesija; Arun Paul
Journal:  Contemp Clin Dent       Date:  2018 Apr-Jun

8.  Osteoradionecrosis prevalence and associated factors: A ten years retrospective study.

Authors:  I-F Pereira; R-T Firmino; H-C Meira; B-C-E Vasconcelos; V-R-A-S Noronha; V-R Santos
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-11-01

9.  Protective effects of α‑2‑macroglobulin on human bone marrow mesenchymal stem cells in radiation injury.

Authors:  Yang Liu; Wanting Cao; Xiangbo Kong; Jie Li; Xueying Chen; Yaping Ge; Wanzhen Zhong; Silian Fang
Journal:  Mol Med Rep       Date:  2018-09-04       Impact factor: 2.952

10.  Outcomes of Radiotherapy for Osseous Echinococcosis of Meriones meridianus.

Authors:  Chao Ma; Xuefeng Luo; Wuluhan Mahan; Yahui Tang; Yun Duan; Rui Mao; Zengru Xie
Journal:  Biomed Res Int       Date:  2020-08-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.